Sleep
apnea is a chronic respiratory sleep disorder that is
commonly characterized by disruption of breathing while sleeping.
This is characterized by conditions such as shallow periods of
breathing or occurrence of breaks and pauses during sleep. The
duration pauses can be for a few seconds or can last for several
minutes. These disruptive events can occur multiple times during the
night. People with loud snoring habits are most vulnerable to sleep
apnea. Resumption of breathing after these pauses are mostly followed
by choking or snorting sounds. Most people remain undiagnosed of
sleep apnea, as it occurs during the night and is difficult to be
detected during routine hospital visits. Apnea essentially is the
squeezing of air that passes the blockage, while breathing and
results in loud snoring. These blockages are mostly encountered in
overweight and obese people. People suffering from diabetes are more
likely to be victims of sleep apnea. Three major types of sleep apnea
are obstructive sleep apnea (OSA), central sleep apnea (CSA) and
mixed sleep apnea, which is a combination of the two. Obstructive
sleep apnea is the most commonly found form of sleep apnea in which
the breathing is interrupted by blockage of airflow.
To
Download PDF Copy of This Exclusive Report at
https://www.coherentmarketinsights.com/insight/request-sample/414
The
North American share to contribute the highest of the sleep apnea
devices market
North
America dominates the global sleep apnea devices market, followed by
Europe and Asia Pacific respectively. High awareness among the
populace and favorable reimbursement scenario make North America a
key market for sleep apnea devices. Several other factors such as
venture capital funding, new legislation of PAP devices and growth of
funding and grants for development in manufacturing units of sleep
apnea devices are prime reasons to boost market growth in several
European countries.
Well
established presence of multiple sleep apnea treating devices results
in dominance of ResMed Inc (US) on global sleep apnea devices market
The
global sleep apnea devices market is prominently driven by key
players such as
•
ResMed Inc.
•
Phillips Healthcare
•
Fisher and Paykel Healthcare Ltd.
These
companies have their products selling over several countries,
prominently in US and Europe, and has established a dominance in the
field of sleep apnea devices industry due to their high investments
in R&D and distribution force of strong sales. Following are the
other players in global sleep apnea devices market which include
SomnoMed Ltd., Weinmann Medical Devices GmbH, Compumedics Ltd., Whole
You Inc., BMC Medical Co. Ltd, and Braebon Medical Corporation.
Positive
Airway Pressure (PAP) devices segment to account for highest share of
the global sleep apnea devices market:
The
global sleep apnea devices market can be segmented on the basis of
product type and end users.
1.
On the basis of product type, the global market can be
segmented as:
Therapeutic
devices - These are further sub- segmented as:
•
PAP devices
•
Facial interfaces
•
Oxygen concentrators
•
Adaptive servo- ventilation instruments
•
Airway clearance systems
•
Others
Diagnostic
devices- These are further sub- segmented as:
•
Polysomnography (PSG) devices
•
Respiratory polygraphs
•
Single channel screening devices
•
Actigraphy systems
2.
On the basis of end user, the global market can be
segmented as:
•
Hospitals
•
Home Care Settings
•
Sleep Laboratories
•
Others
If
You Have Specific Requirement? Ask Our Experts @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/414
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment